论文部分内容阅读
目的:针对胺碘酮在心力衰竭合并心律失常治疗中常见的不良反应,探讨相应的解决措施。方法:在我院收治的心力衰竭合并心律失常患者中选取60例作为此次研究对象,先进行抗心力衰竭治疗,同时使用胺碘酮进行治疗,在治疗过程中进行严密的监测,观察患者治疗过程中的不良反应发生情况。结果:60例心力衰竭合并心律失常患者,经过针对性的治疗之后,窦性心律恢复率为95.0%。结论:对于心力衰竭合并心律失常患者,在使用胺碘酮进行治疗的过程中,实施针对性的系统治疗,严密监测患者的生命体征,进而合理用药,可提高治疗效果,具有一定的临床应用价值。
Objective: To address the common adverse reactions of amiodarone in the treatment of heart failure combined with arrhythmia, and to explore the corresponding solutions. Methods: 60 patients with heart failure and arrhythmia admitted to our hospital were selected as the object of this study. The patients were treated with anti-heart failure and amiodarone at the same time. During the course of treatment, strict monitoring was performed to observe the patient’s treatment The occurrence of adverse reactions in the process. Results: In 60 patients with heart failure and arrhythmia, after targeted therapy, the recovery rate of sinus rhythm was 95.0%. Conclusion: In patients with heart failure and arrhythmia, during the course of treatment with amiodarone, targeted systematic treatment is carried out, the vital signs of patients are closely monitored, and then the rational use of drugs can improve the therapeutic effect, and has certain clinical value .